• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于卟啉的超分子纳米纤维作为一种动态和可激活的光动力治疗光敏剂。

Porphyrin-based supramolecular nanofibres as a dynamic and activatable photosensitiser for photodynamic therapy.

机构信息

Department of Organic Chemistry, Universidad Autónoma de Madrid, Institute for Advanced Research in Chemical Sciences, Calle Francisco Tomás y Valiente, 7, 28049 Madrid, ES, Spain.

IMDEA Nanociencia, c/Faraday 9, Cantoblanco, 28049, ES, Spain.

出版信息

Biomater Sci. 2022 Jun 14;10(12):3259-3267. doi: 10.1039/d2bm00173j.

DOI:10.1039/d2bm00173j
PMID:35583002
Abstract

Photodynamic therapy (PDT) represents a promising treatment modality for a range of cancers and other non-malignant diseases due to its non-invasive nature arising from the light-dependent activation. However, PDT has not been the first-line treatment of cancer thus far as a consequence of, among others, the lack of effective transport and activation strategies, and the undesired side effect caused by skin photosensitisation induced by the "always on" photosensitisers. To overcome this "Achilles' heel", we present herein a non-covalent approach to construct a one-component dynamic supramolecular nanophotosensitising system based on a carefully designed porphyrin. The control of the photoactivities of the resulting supramolecular fibres lies in the spatiotemporal control of the monomer-polymer equilibrium. Both the thermodynamics and kinetics of this nanosystem have been carefully studied by different techniques. Moreover, and studies have also been performed, showing that these supramolecular aggregates exhibit facile cell internalisation and progressive disassembly after being endocyted by targeted cells, leading to activation of the photosensitising units and eventually cell death and tumour eradication under photoirradiation.

摘要

光动力疗法(PDT)由于其基于光依赖性激活的非侵入性特性,代表了一系列癌症和其他非恶性疾病的有前途的治疗方式。然而,由于缺乏有效的传输和激活策略,以及由“始终开启”光敏剂引起的皮肤光致敏引起的不期望的副作用,PDT 迄今为止尚未成为癌症的一线治疗方法。为了克服这一“阿喀琉斯之踵”,我们在此提出了一种非共价方法,基于精心设计的卟啉构建了一种单一组分的动态超分子纳米光敏化系统。所得超分子纤维光活性的控制在于单体-聚合物平衡的时空控制。通过不同的技术,仔细研究了这个纳米系统的热力学和动力学。此外,还进行了 和 研究,表明这些超分子聚集体在被靶向细胞内吞后表现出易于细胞内化和渐进解体,导致光敏化单元的激活,并最终在光照射下导致细胞死亡和肿瘤消除。

相似文献

1
Porphyrin-based supramolecular nanofibres as a dynamic and activatable photosensitiser for photodynamic therapy.基于卟啉的超分子纳米纤维作为一种动态和可激活的光动力治疗光敏剂。
Biomater Sci. 2022 Jun 14;10(12):3259-3267. doi: 10.1039/d2bm00173j.
2
Supramolecular photosensitizers rejuvenate photodynamic therapy.超分子光敏剂使光动力疗法重焕生机。
Chem Soc Rev. 2018 Feb 21;47(4):1174-1188. doi: 10.1039/c7cs00594f. Epub 2018 Jan 15.
3
Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models.使用二磺化二氢卟酚和卟啉光敏剂进行光化学内化的疗效:在二维和三维前列腺癌模型中的体外研究
Cancer Lett. 2017 May 1;393:68-75. doi: 10.1016/j.canlet.2017.02.018. Epub 2017 Feb 20.
4
Photodynamic therapy in oncology.肿瘤学中的光动力疗法。
Expert Opin Pharmacother. 2001 Jun;2(6):917-27. doi: 10.1517/14656566.2.6.917.
5
Photodynamic therapy in the treatment of cancer: current state of the art.光动力疗法治疗癌症:当前技术水平
Drugs. 1999 May;57(5):725-34. doi: 10.2165/00003495-199957050-00005.
6
Novel meso-substituted porphyrin derivatives and its potential use in photodynamic therapy of cancer.新型介孔取代卟啉衍生物及其在癌症光动力治疗中的潜在应用。
BMC Cancer. 2021 May 13;21(1):547. doi: 10.1186/s12885-021-08286-6.
7
Current status of photodynamic therapy in oncology.光动力疗法在肿瘤学中的现状
Drugs. 1994 Oct;48(4):510-27. doi: 10.2165/00003495-199448040-00003.
8
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.优化光动力疗法的机制:第二代光敏剂与丝裂霉素C联合使用
Br J Cancer. 1995 Aug;72(2):344-50. doi: 10.1038/bjc.1995.336.
9
Tumour-targeting photosensitisers for one- and two-photon activated photodynamic therapy.用于单光子和双光子激活光动力疗法的肿瘤靶向光敏剂。
Org Biomol Chem. 2019 Jul 21;17(27):6585-6594. doi: 10.1039/c9ob00731h. Epub 2019 Apr 29.
10
In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.一种用于光动力疗法的原卟啉IX-环RGD肽缀合物的体内和体外表征
Photochem Photobiol Sci. 2008 Mar;7(3):290-8. doi: 10.1039/b715141a. Epub 2007 Dec 18.

引用本文的文献

1
Supramolecular nanomedicine in the intelligent cancer therapy: recent advances and future.智能癌症治疗中的超分子纳米医学:最新进展与未来展望
Front Pharmacol. 2024 Oct 11;15:1490139. doi: 10.3389/fphar.2024.1490139. eCollection 2024.
2
Applications of supramolecular assemblies in drug delivery and photodynamic therapy.超分子组装体在药物递送和光动力疗法中的应用。
RSC Med Chem. 2023 Oct 5;14(12):2438-2458. doi: 10.1039/d3md00396e. eCollection 2023 Dec 13.
3
Two birds one stone: β-fluoropyrrolyl-cysteine SAr chemistry enabling functional porphyrin bioconjugation.
一石二鸟:β-氟吡咯基-半胱氨酸SAr化学实现功能性卟啉生物共轭
Chem Sci. 2023 Jan 17;14(8):2070-2081. doi: 10.1039/d2sc06209g. eCollection 2023 Feb 22.
4
Glycosylated BODIPY- Incorporated Pt(II) Metallacycles for Targeted and Synergistic Chemo-Photodynamic Therapy.糖基化 BODIPY 嵌入的 Pt(II) 金属环合物用于靶向协同化化疗-光动力疗法。
J Med Chem. 2023 Mar 9;66(5):3448-3459. doi: 10.1021/acs.jmedchem.2c01940. Epub 2023 Feb 21.